PATENT CLAIM ANALYSIS

Application Number: 16149142
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["514", "019300"]

Abstract:
Provided is a peptide for targeting gastric cancer, a composition for diagnosing radioresponsiveness-dependent gastric cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.

Claim (Index 3):
The method of  claim 1 , wherein the peptide consists of an amino acid selected from the group consisting of SEQ ID NOs: 1 to 3 specific to an irradiated gastric cancer tissue.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 97.0
- Lexical Diversity: 1.54717
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15527716', '14499201', '12844018', '15575390', '11592451']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8034569500572499
- 35 USC 102 Novelty (BERT): 0.5053992919084737
- Combined Prediction Score: 0.7736511842423723
- Mean Citation Score: 241.089552
- Max Citation Score: 280.04465
- Similarity Product: 212.58181593698265

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test